AUGMENTED ANATOMY
Last board
8 directors, 2 in day-to-day management, last change in 2025Passion4Growth
Director and managing director, permanent representative Jörgen Schaffers
appointed by deed of 08-07-2022
term without a fixed end
Passion4Growth BV
Director and managing director
director since 24-02-2022
director appointed by deed of 08-07-2022
listed in the 2025 annual accounts, filed on 31-08-2026
Director
since 28-04-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 31-08-2026
Director
since 06-09-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 31-08-2026
Director, permanent representative Mario Debel
since 01-07-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 31-08-2026
- Passion4Growth, Passion4Growth
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 10-05-2023
Permanent representatives 2
Mandates through the years
12 names, the dashed line is todayBenoit HENDRICKX
Director
Director
Karl WAKED
Director
Director
Passion4Growth
Director, Managing director
Director, Managing director
Passion4Growth BV
Director
Director
Passion4Growth
Director, Managing director
Director, Managing director
Verbraken Mathieu
Director
Director
MD CONSULT BV
Director
Director
Thierry Haezevoets
Board
Board
Joris De Ranter
Director
Director
Decroos Isabelle
Director
Director
Thierry HAZEVOETS
Director
Director
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
- Benoit HENDRICKX
- Director, from 31-07-2020 to date
- Karl WAKED
- Director, from 05-04-2021 to date
- Passion4Growth
- Director, appointed by deed of 08-07-2022, still in office
- Managing director, appointed by deed of 08-07-2022, still in office
- Passion4Growth BV
- Director, from 24-02-2022 to date
- Passion4Growth
- Director, appointed by deed of 08-07-2022, still in office
- Managing director, appointed by deed of 08-07-2022, still in office
- LAUREYS Benedicte Raoul Regine Marc
- Director, since before 31-12-2022
- Verbraken Mathieu
- Director, from 06-09-2024 to date
- MD CONSULT BV
- Director, from 01-07-2025 to date
- Thierry Haezevoets
- Board, from 05-04-2021 to 01-07-2025
- Joris De Ranter
- Director, appointed by deed of 29-10-2021, until 24-10-2024
- Decroos Isabelle
- Director, from before 31-12-2022 to 07-08-2024
- Thierry HAZEVOETS
- Director, appointed by deed of 29-10-2021, no longer listed in the 2025 annual accounts
Control
23.38%
This company
AUGMENTED ANATOMY
Equity €104,775
Loss €872,850 in 2025
Capital
- Contribution
- €3,390,126.43
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- AMBO HOLDING
- MD CONSULT
Source: lists of holdings in the owners' accounts
Articles of association
deed of 10-05-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director“Alle handelingen nodig of dienstig voor voorwerp behalve wet of statuten aan algemene vergadering voorbehouden, gewone meerderheid aanwezige…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 20:00
Shareholders
2 ownersOwners 2
- Equity €178.4m Profit of €12.0m in 2025 (profit of €10.7m in 2024)23.38%
- Equity €3.6m Loss of €492,380 in 2025 (profit of €92,732 in 2024) Checked score 8120%
Capital transactions
Shareholders according to the deeds
After the capital increase
deed of 12-08-2020 ↗
- HENDRICK Benoit 624 shares · €78,000 in cash
- HAZEVOETS Thierry 263 shares · €32,875 in cash
- WAKED Karl 100 shares · €12,500 in cash
- MESPREUVE Marc 100 shares · €12,500 in cash
- DE RANTER Joris Jan 513 shares · €64,125 in cash
Capital over time
- 23-12-2025 Capital stated in the deed · €14,618,573
- 16-05-2024 Capital increase of €152,900 · 265,027 new shares
- 10-05-2023 Capital increase of €648,673.43 · 749,578 new shares · in kind
- 10-05-2023 Capital increase of €1,025,000 · 888,333 new shares at €1.15 per share · in cash
- 12-08-2020 Capital increase of €200,000 · to €262,500 · 1,600 new shares at €125 per share · in cash
- 12-08-2020 Converted to unavailable equity · €262,500